Peripheral combination treatment of leptin and an SGLT2 inhibitor improved glucose metabolism in insulin-dependent diabetes mellitus mice-Reference-Cited by-同舟云学术

Peripheral combination treatment of leptin and an SGLT2 inhibitor improved glucose metabolism in insulin-dependent diabetes mellitus mice

Published:2021-12 Issue:4 Volume:147 Page:340-347
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:Journal of Pharmacological Sciences

Author:

Yaginuma Hiroshi,Banno Ryoichi,Sun Runan,Taki Keigo,Mizoguchi Akira,Kobayashi Tomoko,Sugiyama Mariko,Tsunekawa Taku,Onoue Takeshi,Takagi Hiroshi,Hagiwara Daisuke,Ito Yoshihiro,Iwama Shintaro,Suga Hidetaka,Arima Hiroshi

Funder

Japan IDDM network

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Pharmacology,Molecular Medicine

Reference40 articles.

1. Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences;Gallo;Diabetes Vasc Dis Res,2015

2. The mechanisms and therapeutic potential of SGLT2 inhibitors in diabetes mellitus;Vallon;Annu Rev Med,2015

3. Renoprotective effects of sodium-glucose cotransporter-2 inhibitors;Heerspink;Kidney Int,2018

4. SGLT2 inhibitors: a review of their antidiabetic and cardioprotective effects;Tentolouris;Int J Environ Res Publ Health,2019

5. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes;Zinman;N Engl J Med,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Neuronal and Non-Neuronal Pathways of Sodium-Glucose Cotransporter-2 Inhibitor on Body Weight-Loss and Insulin Resistance;Diabetes, Metabolic Syndrome and Obesity;2023-02

2. Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy;Frontiers in Bioscience-Landmark;2022-12-12

3. Protein Tyrosine Phosphatase 1B Deficiency Improves Glucose Homeostasis in Type 1 Diabetes Treated With Leptin;Diabetes;2022-06-24